MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH 2-terminal kinase and nuclear factor-κB activation in human pancreatic islet cells

Diabetes

Volumn 57, Issue 7, 2008, Pages 1896-1904

  Mokhtari, Dariush ^a   Myers, Jason W ^b   Welsh, Nils ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; COMPLEMENTARY DNA; MAP3K1 PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MOUSE; MUTANT; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; METABOLISM; PANCREAS ISLET; PHOSPHORYLATION; PHYSIOLOGY; REPORTER GENE;

ANIMALS; CELL DEATH; CYTOKINES; DNA, COMPLEMENTARY; ENZYME INDUCTION; GENES, REPORTER; HUMANS; ISLETS OF LANGERHANS; MAP KINASE KINASE KINASE 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RNA, SMALL INTERFERING;

EID: 48249113845     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1670     Document Type: Article

References (50)

1. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 8:291-297, 1996
2. Eizirik DL, Mandrup-Poulsen T: A choice of death: the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115-2133, 2000
3. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A: β-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cell and proinflammatory cytokine expression in islets. Diabetes 48:21-28, 1999
4. Uno S, Imagawa A, Okita K, Sayama K, Moriwaki M, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I: Macrophages and dendritic cells infiltrating islets with or without beta- cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 50:596- 601, 2007
5. Welsh N: Interleukin-1beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun-NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 271:8307-8312, 1996
6. Larsen CM, Wadt KA, Juhl LF, Andersen HU, Karlsen AE, Su MS, Seedorf K, Shapiro L, Dinarello CA, Mandrup-Poulsen T: Interleukin-1β-induced rat pancreatic islet NO synthesis requires both the p38 and extracellular-signal regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem 273:15294-15300, 1998
7. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF: Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes 50:77-82, 2001
8. Saldeen J, Lee JC, Welsh N: Role of p38 MAPK in cytokine-induced rat islet cell apoptosis. Biochem Pharmacol 61:561-569, 2001
9. Flodstrom M, Welsh N, Eizirik DL: Cytokines activate the nuclear factor kB (NF-κB) and induces nitric oxide production in human pancreatic islets. FEBS Lett 385:4-6, 1996
10. Saldeen J, Welsh N: Interleukin-1β induced activation of NF-κB in insulin producing RIN5mF cells is prevented by the protease inhibitor tosyllysine chloromethyl ketone. Biochem Biophys Res Commun 203:149-155, 1994
11. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK and p38 protein kinases. Science 298:1911-1919, 2002
12. Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL: MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol 18:2416-2429, 1998
13. Hu WH, Johnson H, Shu HB: Tumor necrosis factor-related apoptosis- inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways. J Biol Chem 274:30603-30610, 1999
14. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR: Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway. J Biol Chem 273:12901-12908, 1998
15. Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 103:239-252, 2000
16. Lu Z, Xu S, Joazeiro C, Cobb CH, Hunter T: The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol Cell 9:945-956, 2002
17. Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227, 2002
18. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL: Inhibition of cytokine-induced NF-κB activation by adenovirus- mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50:2219-2224, 2001
19. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, Melloul D: Conditional and specific NF-kB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad SciUSA103:5072-5077, 2006
20. Meyer CF, Wang X, Widmann C, Chang C, Templeton D, Tan TH: Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J Biol Chem 271:8971-8976, 1996
21. Mokhtari D, Myers JW, Welsh N: The MAPK kinase kinase-1 is essential for stress-induced pancreatic islet cell death. Endocrinology. In press
22. Myers JW, Ferrell JE: Silencing gene expression with dicer-generated siRNA pools. Methods Mol Biol 309:93-96, 2005
23. Welsh N, Makeeva N, Welsh M: Overexpression of the Shb SH2 domain- protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins. Mol Med 8:695-704, 2002
24. Deak JC, Templeton DJ: Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. Biochem J 322:185-192, 1997
25. Barbu A, Welsh N: Lipofection of insulin-producing RINm5F cells: methodological improvements. J Liposome Res 17:49 - 62, 2007
26. Hagerkvist R, Mokhtari D, Myers J, Tengholm A, Welsh N: siRNA produced by recombinant dicer mediates efficient gene silencing in islet cells. Ann N Y Acad Sci 1040:695-704, 2005
27. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A: Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad SciUSA91:9253-9256, 1994
28. Catterall JB, Carrere S, Koshy PJ, Degnan BA, Shingleton WD, Brinckerhoff CE, Rutter J, Cawston TE, Rowan AD: Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 44:2296-2310, 2001
29. Platanias LC: Mechanisms of type-1 and type-II interferon-mediated signalling. Nat Rev Immunol 5:375-386, 2005
30. Zhang S, Liu J, Dragunow M, Cooper GJ: Fibrilogenic amylin evokes islet-beta-cell apoptosis through linked activation ofa caspase cascade and JNK1. J Biol Chem 278:52810-52819, 2003
31. 31.Abdelli S, Ansite J, Roduit R, Borsello T, Matsumoto I, Sawada T, Allaman-Pillet N, Henry H, Beckman JS, Hering BJ, Bonny C: Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 53:2815-2823, 2004
32. Hammaker DR, Boyle DL, Inoue T, Firestein GS: Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther 9:R57, 2007
33. Hammaker DR, Boyle DL, Chabaud-Riou M, Firestein GS: Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. J Immunol 172:1612-1618, 2004
34. Hehner SP, Hofmann TG, Ushmorov A, Dienz O, Wing-Lan Leung I, Lassam N, Scheidereit C, Droge W, Schmitz ML: Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol 20:2556-2568, 2000
35. Xia Y, Makris C, Su B, Li E, Yang J, Nemerow GR, Karin M: MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad SciUSA9:5243-5248, 2000
36. Nemoto S, DiDonato JA, Lin A: Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB inducing kinase. Mol Cell Biol 18:3537-3542, 1998
37. Li X, Zhang R, Luo D, Park SJ, Wang Q, Kim Y, Min W: Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal- regulating kinase 1-JNK/p38 activation. J Biol Chem 280:15061-15070, 2005
38. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Schulz R, Lakey JR, Warnock GL, Rajotte RV: Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 79:1058-1062, 1994
39. Eizirik DL, Darville MI: β-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes 50 (Suppl. 1):S64-S69, 2001
40. Ammendrup A, Maillard A, Nielsen K, Aabenhus Anderssen N, Serup P, Dragsbaek Madsen O, Mandrup-Poulsen T, Bonny C: The c-Jun amino- terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cell. Diabetes 49:1468-1476, 2000
41. Oetjen E, Blume R, Cierny I, Schlag C, Kutschenko A, Krätzner R, Stein R, Knepel W: Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1β and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia 50:1678-1687, 2007
42. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M: Differential activation of ERK and JNK mitogen- activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723,1994
43. Makeeva N, Roomans GM, Myers JW, Welsh N: TAB1{alpha}, but not TAB1{beta}, mediates cytokine-induced p38 MAPK phosphorylation and cell death in insulin producing cells. Endocrinology 149:302-309, 2008
44. Makeeva N, Myers JW, Welsh N: Role of MKK3 and p38 MAPK in cytokine-induced death of insulin producing cells. Biochem J 393:129-139, 2006
45. Siow YL, Kalmar GB, Sanghera JS, Tai G, Oh SS, Pelch SL: Identification of two essential threonine residues in the catalytic domain of Mekk1: indirect activation by Pak3 and protein kinase C. J Biol Chem 272:7586-7594, 1997
46. Fanger GR, Johnson NL, Johnson GL: MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J 16:4961-4972, 1997
47. Kim JW, Joe CO, Choi EJ: Role of receptor-interacting protein in tumor necrosis factor-alpha-dependent MEKK1 activation. J Biol Chem 276: 27064-27070, 2001
48. Chadee DN, Yuasa T, Kyriakis JM: Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adaptor protein TRAF2. Mol Cell Biol 22:737-749, 2002
49. Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, Molkentin JD, Zheng Y, Xia Y: MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 25:60-65, 2005
50. Holm P, Rydlander B, Luthman H, Kockum I: Interaction and association analysis of a type 1 diabetes susceptibility locus on chromosome 5q11-q13 and the 7q32 chromosomal region in Scandinavian families. Diabetes 53:1584-1591, 2004